Literature DB >> 30807681

Most gene fusions in cancer are stochastic events.

Bertil Johansson1,2, Fredrik Mertens1,2, Tommy Schyman3, Jonas Björk3, Nils Mandahl1, Felix Mitelman1.   

Abstract

Cancer-associated gene fusions resulting in chimeric proteins or aberrant expression of one or both partner genes are pathogenetically and clinically important in several hematologic malignancies and solid tumors. Since the advent of different types of massively parallel sequencing (MPS), the number of identified gene fusions has increased dramatically, prompting the question whether they all have a biologic impact. By ascertaining the chromosomal locations of 8934 genes involved in 10 861 gene fusions reported in the literature, we here show that there is a highly significant association between gene content of chromosomes and chromosome bands and number of genes involved in fusions. This strongly suggests that a clear majority of gene fusions detected by MPS are stochastic events associated with the number of genes available to participate in fusions and that most reported gene fusions are passengers without any pathogenetic importance.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  cancer; chromosome bands; chromosomes; gene content; gene fusions

Mesh:

Year:  2019        PMID: 30807681     DOI: 10.1002/gcc.22745

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  7 in total

1.  Expanding the spectrum of mesenchymal neoplasms with NR1D1-rearrangement.

Authors:  Maribel D Lacambra; Cristina R Antonescu; Chit Chow; Wang Kei Chiu; Elizabeth G Demicco; Peter C Ferguson; David Swanson; Ka-Fai To; Lei Zhang; Brendan C Dickson
Journal:  Genes Chromosomes Cancer       Date:  2022-03-16       Impact factor: 4.263

2.  Transfer of healthy fibroblast-derived mitochondria to HeLa ρ0 and SAS ρ0 cells recovers the proliferation capabilities of these cancer cells under conventional culture medium, but increase their sensitivity to cisplatin-induced apoptotic death.

Authors:  Amaneh Mohammadi Roushandeh; Kazuo Tomita; Yoshikazu Kuwahara; Ali Jahanian-Najafabadi; Kento Igarashi; Mehryar Habibi Roudkenar; Tomoaki Sato
Journal:  Mol Biol Rep       Date:  2020-05-11       Impact factor: 2.316

Review 3.  Interstitial Deletions Generating Fusion Genes.

Authors:  Ioannis Panagopoulos; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2021 May-Jun       Impact factor: 4.069

4.  Fusions involving BCOR and CREBBP are rare events in infiltrating glioma.

Authors:  David J Pisapia; Kentaro Ohara; Rohan Bareja; David C Wilkes; Erika Hissong; Jaclyn A Croyle; Joon-Hyung Kim; Jad Saab; Theresa Y MacDonald; Shaham Beg; Catherine O'Reilly; Sarah Kudman; Mark A Rubin; Olivier Elemento; Andrea Sboner; Jeffrey Greenfield; Juan Miguel Mosquera
Journal:  Acta Neuropathol Commun       Date:  2020-06-03       Impact factor: 7.801

Review 5.  Fusion transcripts: Unexploited vulnerabilities in cancer?

Authors:  Carla Neckles; Soumya Sundara Rajan; Natasha J Caplen
Journal:  Wiley Interdiscip Rev RNA       Date:  2019-08-13       Impact factor: 9.957

6.  Pan-Cancer Analysis Reveals the Diverse Landscape of Novel Sense and Antisense Fusion Transcripts.

Authors:  Neetha Nanoth Vellichirammal; Abrar Albahrani; Jasjit K Banwait; Nitish K Mishra; You Li; Shrabasti Roychoudhury; Mathew J Kling; Sameer Mirza; Kishor K Bhakat; Vimla Band; Shantaram S Joshi; Chittibabu Guda
Journal:  Mol Ther Nucleic Acids       Date:  2020-01-29       Impact factor: 8.886

7.  Whole transcriptome sequencing detects a large number of novel fusion transcripts in patients with AML and MDS.

Authors:  Anna Stengel; Rabia Shahswar; Torsten Haferlach; Wencke Walter; Stephan Hutter; Manja Meggendorfer; Wolfgang Kern; Claudia Haferlach
Journal:  Blood Adv       Date:  2020-11-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.